Multitrace-4 Neonatal (American Regent, Inc.)
Welcome to the PulseAid listing for the Multitrace-4 Neonatal drug offered from American Regent, Inc.. This Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | American Regent, Inc. |
| NON-PROPRIETARY NAME: | Trace Elements 4 |
| SUBSTANCE NAME: | ZINC SULFATE HEPTAHYDRATE; CUPRIC SULFATE; MANGANESE SULFATE; CHROMIC CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 1990-09-30 |
| END MARKETING DATE: | 0000-00-00 |
Multitrace-4 Neonatal HUMAN PRESCRIPTION DRUG Details:
| Item Description | Multitrace-4 Neonatal from American Regent, Inc. |
| LABELER NAME: | American Regent, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6.6; .39; 77; 4.36(mg/mL; mg/mL; mg/mL; ug/mL) |
| START MARKETING DATE: | 1990-09-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0517-6202_c8aa6a43-0e1f-43e5-a042-e3b3a3e931dd |
| PRODUCT NDC: | 0517-6202 |
| APPLICATION NUMBER: | |
Other ZINC SULFATE HEPTAHYDRATE; CUPRIC SULFATE; MANGANESE SULFATE; CHROMIC CHLORIDE Pharmaceutical Manufacturers / Labelers:
